1. Escalating dose-regimen of intraperitoneal mitox-antrone. Phase-1 study-clinical and pharmacokinetic evaluation;Blochl-Daum;Europ. J. Cancer. clin. Oncol.,1988
2. Changes in glutathione metabolism following exposure to alkylating agents in human ovarian tumour biopsies;Britten;Proc. Amer. Ass. Cancer Res.,1989
3. Glutathione-S-transferases and drug resistance;Cowan;Proc. Amer. Ass. Cancer Res.,1989
4. Anti-tumour activity of mitoxantrone against experimental tumour: comparative analysis against various anti-tumour antibiotics;Fujimoto;Cancer Chemother. Pharmacol.,1982
5. Antineoplastic chemotherapy myelosuppression: mechanism and new approaches;Gale;Exp. Hematol. (Suppl. 16),1985